- Home
- NERV vs FLYE Comparison
NERV vs FLYE Comparison
Compare NERV & FLYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- FLYE
- Stock Information
- Founded
- NERV 2007
- FLYE 2018
- Country
- NERV United States
- FLYE United States
- Employees
- NERV N/A
- FLYE N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- FLYE Aerospace
- Sector
- NERV Health Care
- FLYE Industrials
- Exchange
- NERV Nasdaq
- FLYE Nasdaq
- Market Cap
- NERV 12.6M
- FLYE 10.2M
- IPO Year
- NERV 2014
- FLYE 2024
- Fundamental
- Price
- NERV $1.77
- FLYE $0.92
- Analyst Decision
- NERV Hold
- FLYE
- Analyst Count
- NERV 1
- FLYE 0
- Target Price
- NERV $5.00
- FLYE N/A
- AVG Volume (30 Days)
- NERV 12.2K
- FLYE 883.1K
- Earning Date
- NERV 08-05-2025
- FLYE 08-18-2025
- Dividend Yield
- NERV N/A
- FLYE N/A
- EPS Growth
- NERV N/A
- FLYE N/A
- EPS
- NERV 0.83
- FLYE N/A
- Revenue
- NERV N/A
- FLYE $28,547,111.00
- Revenue This Year
- NERV N/A
- FLYE N/A
- Revenue Next Year
- NERV N/A
- FLYE N/A
- P/E Ratio
- NERV $2.18
- FLYE N/A
- Revenue Growth
- NERV N/A
- FLYE N/A
- 52 Week Low
- NERV $1.15
- FLYE $0.33
- 52 Week High
- NERV $3.50
- FLYE $7.30
- Technical
- Relative Strength Index (RSI)
- NERV 57.10
- FLYE N/A
- Support Level
- NERV $1.62
- FLYE N/A
- Resistance Level
- NERV $1.83
- FLYE N/A
- Average True Range (ATR)
- NERV 0.09
- FLYE 0.00
- MACD
- NERV -0.00
- FLYE 0.00
- Stochastic Oscillator
- NERV 64.29
- FLYE 0.00
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About FLYE Fly-E Group Inc. Common Stock
Fly-E Group Inc is an electric vehicle company that is principally engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters and related accessories under the brand Fly E-Bike. It also provides connectivity solutions and value-added services to their customers.